(Q48866922)

English

The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Parkinson's disease

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

Rüdiger Hilker

8

object named as

Rüdiger Hilker

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

1

object named as

Simon Baudrexel

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

author name string

Carola Seifried

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Bianca Penndorf

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Johannes C Klein

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Marcus Middendorp

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Helmuth Steinmetz

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Frank Grünwald

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

language of work or name

0 references

publication date

15 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

29

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

380-387

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Multiple system atrophy: a review of 203 pathologically proven cases

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

FDG PET in the differential diagnosis of parkinsonian disorders

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Second consensus statement on the diagnosis of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Abnormal regional brain function in Parkinson's disease: truth or fiction?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

pROC: an open-source package for R and S+ to analyze and compare ROC curves

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Diffusion tensor imaging: concepts and applications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Oxidative and nonoxidative metabolism of excited neurons and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Network correlates of disease severity in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Comparison of diffusion tensor imaging measurements at 3.0 T versus 1.5 T with and without parallel imaging.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Brain damage from anticancer treatments in adults

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25749

21 January 2018

Identifiers

10.1002/MDS.25749

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24243813

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48866922&oldid=2212542310"